From tax breaks to Obamacare repeal, medtech companies are likely due to experience major changes under President Donald Trump. The situation, though, remains unpredictable.
“I don’t think that there has been a scenario, not since I’ve been a professional and in politics, where we really know so little about exactly what the key priorities are that are going to impact our industry,” Shaye Mandle, president and CEO of the Medical Alley Association in Minnesota, recently told MDO.
By
Image courtesy of Zach Rudisin, CC BY-SA 3.0
